Sunlight, Vitamin D and Skin Cancer 2014
DOI: 10.1007/978-1-4939-0437-2_13
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Biology of Basal and Squamous Cell Carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0
5

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(28 citation statements)
references
References 195 publications
0
23
0
5
Order By: Relevance
“…Several somatic mutations have been associated with the development of BCC, including PTCH , SMOH , SUFUH , and TP53 (Reifenberger et al, ). The constitutive activation of the sonic hedgehog signaling pathway by acquired mutations in the PTCH and SMO genes appears to represent an early determinant of BCC development (Emmert, Schon, & Haenssle, ). A loss of function of TP53 , a tumor suppressor gene encoding a protein causing cell cycle arrest in the presence of DNA damage, was frequently associated with BCC as well as with many other cancers (Heller et al, ; Reifenberger et al, ).…”
Section: Geneticsmentioning
confidence: 99%
“…Several somatic mutations have been associated with the development of BCC, including PTCH , SMOH , SUFUH , and TP53 (Reifenberger et al, ). The constitutive activation of the sonic hedgehog signaling pathway by acquired mutations in the PTCH and SMO genes appears to represent an early determinant of BCC development (Emmert, Schon, & Haenssle, ). A loss of function of TP53 , a tumor suppressor gene encoding a protein causing cell cycle arrest in the presence of DNA damage, was frequently associated with BCC as well as with many other cancers (Heller et al, ; Reifenberger et al, ).…”
Section: Geneticsmentioning
confidence: 99%
“…Hedgehog (HH) pathway is the key event in the initiation of the pathogenesis of BCC. Abnormal activation of HH signaling results in constitutive activation of target genes that drive the oncogenesis of BCC, including SHH (600725), SMO (601500), GLI1 (165220), and GLI2 (165230) (Emmert, Schon, & Haenssle, ; Otsuka, Levesque, Dummer, & Kabashima, ; Wong & Dlugosz, ). Transgenic mouse models have been used to confirm the essential role of HH pathway in BCC formation.…”
Section: Introductionmentioning
confidence: 99%
“…Zaburzenia aktywności szlaku SHH stwierdzane w BCC są spowodowane mutacjami genu supresorowego PTCH1 (protein patched homolog 1), którego produkt białkowy (Ptc) stanowi element szlaku SHH. Mutacje genu PTCH1 wykazano także w wielu innych typach nowotworów, co wskazuje na jego istotną rolę w regulacji proliferacji komórek [35,38,39]. W rozwoju BCC kluczowe są także mutacje genu supresorowego P53, stwierdzane w 44-100% przypadków tego raka.…”
Section: Rak Podstawnokomórkowyunclassified